Vistagen Therapeutics SEC Filings
NASDAQ: VTGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.2361-0.0101 (-4.10%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vistagen Therapeutics filing overview
This page lists 1 recent SEC filings by Vistagen Therapeutics (VTGN), including 1 8-K. The latest current report (8-K), used to disclose material events such as earnings releases and executive changes, was filed on Oct 9, 2026. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
VTGN SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Oct 9, 2026 | 8-K | Departure or Appointment of Directors or Officers; Compensatory Arrangements | View on EDGAR |